Daré Bioscience, Inc.
DARE
$1.85
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 73.82% | 24.24% | -131.11% | 35.19% | -8.87% |
| Total Depreciation and Amortization | 8,250.00% | 4,868.04% | 2,887.66% | 1,363.89% | -36.00% |
| Total Amortization of Deferred Charges | -520.55% | -- | -127.83% | 2,400.00% | -- |
| Total Other Non-Cash Items | -47.65% | -13.07% | -16.19% | -65.88% | 249.05% |
| Change in Net Operating Assets | -79.17% | 200.07% | -216.11% | -17.11% | 482.57% |
| Cash from Operations | -72.78% | 92.54% | -141.98% | 19.70% | 164.87% |
| Capital Expenditure | 63.29% | -161.88% | 153.79% | -2,054.79% | 7.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 63.29% | -161.88% | 153.79% | -2,054.79% | 7.33% |
| Total Debt Issued | -- | -13.35% | -- | -- | -- |
| Total Debt Repaid | -182.59% | -365.14% | -680.39% | 6.59% | 6.59% |
| Issuance of Common Stock | 2,196.94% | -- | 159.56% | 102.79% | -92.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -304.15% | -- | 412.50% | -257.14% | -101.69% |
| Cash from Financing | 300.71% | 4,173.65% | -137.95% | 1,661.43% | -103.98% |
| Foreign Exchange rate Adjustments | 61.18% | -69.87% | -11.64% | 133.42% | -212.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -63.36% | 448.11% | -141.53% | 21.58% | 230.63% |